Visiongain publishes Global Cardiovascular Ultrasound Market Report 2020-2030

09 June 2020
Pharma

Visiongain has launched a new report Global Cardiovascular Ultrasound Market Report 2020-2030: Forecasts by Test Type (Transthoracic Echocardiography, Transoesophageal Echocardiography, Stress Echocardiography), Display Type (Colour Display, Black & White Display), by Technology (2D, 3D, 4D), by End-User (Hospitals, Ambulatory Centers, Diagnostic Centers), by Portability (Fixed Devices, Portable Devices, Hand-Held Devices) PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis.

The new report from business intelligence provider Visiongain offers an updated outlook for the global market for cardiovascular ultrasound. Visiongain assesses that the cardiovascular ultrasound market will generate revenues of $xyz million by 2030 and there will be around 177 thousand units in the world. Ultrasounds as an imaging surgical tool are becoming ever more important globally. Ultrasound technology is developing quickly, and several companies are developing contactless, user-friendly devices for an enhanced user experience. The use of very concentrated ultrasound has increased during neurosurgery. The current period of fast growth of medical ultrasound is, as it has a major clinical impact. The quality of the images produced by ultrasound instruments has enormously increased and the time taken for pictures / turnaround has decreased significantly. Visiongain’s study is intended for anyone requiring commercial analyses for the Cardiovascular Ultrasound Market and leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Global Market Overview
Global cardiovascular ultrasound market was valued at $xyz million, in 2019 and is anticipated to grow at a CAGR of xyz% from 2020-2030 to reach at market value of $xyz million, by 2030. The market is anticipated to grow at a CAGR of xyz% in the first half of the forecast period while the second half of the forecast period is anticipated to grow at CAGR of xyz%. This is an example of the business-critical headline that you need to know about – and more importantly, you need to read Visiongain’s objective analysis of how this will impact your company and the industry more broadly. How are you and your company reacting to this news? Are you sufficiently informed?

Driving Factors in the Global Market

Rising Incidence of Cardiovascular Disorders and Other Lifestyle Related Disorders
In 2018 approximately 17.9 million deaths from CVDs accounted for 31% of the world's deaths. An estimated 7.4 millions of these deaths were due to cardiac coronary heart disease. The overall prevalence of cardiovascular disease in 2019 was estimated at 522,7 million but the prevalence was significantly varied by country. Death rates were highest in Central Asia and Eastern Europe, but also in Iraq, Afghanistan, and many countries of the South Pacific island.

Increasing Demand for Minimally Invasive Surgeries
The worldwide focus is on minimally invasive surgeries (MIS). MIS is a successful practice and an alternative to conventional surgery and robotic operation. The minimum invasive procedure for cardiac procedures includes the repair and replacement mitral valve, repair of aortic valves, remediation of auricular septal defects, coronary artery bypassing, removal of cardiac tumors and removal of atrial fibrillation. Combined with medical progress, open surgery in general will soon be outdated and the most accepted method of treatment will be minimally invasive. This success increases cardiovascular ultrasound market growth further. The success of these procedures

Market Opportunity

Increasing Adoption of Telemedicine, Remote Patient Monitoring and Home Healthcare
Remote interpretation of cardiology investigations and patient data is a fast-emerging telecardiology industry. The aim of telecardiology is to provide cardiologist and other caregivers as soon as possible with the necessary and reliable information, preventing the patient's condition from deteriorating, without having to travel either for patients or for cardiologists. Recent studies have recognized home-based telemedicine management programmes. Cryptogenic heart failure and hypertension monitoring and management programs, acute ST elévation IM diagnostics and treatment, and the monitoring of patients with electronic implantable devices, amongst other activities, are the most important programs for disease management. Overall, the increased adoption of telemedicine, remote monitoring and home health care drives the cardiovascular devices market as numerous benchmarks are launched and attractive.

Segmental Insights

Transthoracic Echocardiography segment is set to dominate the market
Global cardiovascular ultrasound market by test type was valued at US$xyz million, in 2019 and is anticipated to grow at a CAGR of xyz% from 2020-2030 to reach at market value of US$xyz million, by 2030. Transthoracic Echocardiography is anticipated to grow at a CAGR of xyz% from 2020-2030 to reach at a market value of US$xyz million, by 2030. Stress Echocardiography is expected to grow at a CAGR of xyz% from 2020-2030 to reach at a market value of US$xyz million, by 2030.

Hospitals to hold major share in the market
Global cardiovascular ultrasound market by end-user was valued at US$xyz million, in 2019 and is anticipated to grow at a CAGR of xyz% from 2020-2030 to reach at market value of US$xyz million, by 2030. Hospitals is anticipated to grow at a CAGR of xyz% from 2020-2030 to reach at a market value of US$xyz million, by 2030. Diagnostic Centers is expected to grow at a CAGR of xyz% from 2020-2030 to reach at a market value of US$xyz million, by 2030.

To access the data contained in this document please email contactus@visiongain.com

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Viral Vectors & Plasmid DNA Manufacturing Market Report 2021-2031

Due to increases in the therapies in progress, the dosages provided, & the patient populations targeted, viral vector production capacity has become increasingly reduced in recent years. The condition is aggravated by COVID-19.

03 December 2020

Read

Visiongain Publishes Drugs of Abuse Testing Market Report 2021-2031

Drugs Abuse has risen very significantly in few last year as compared to previous once and expected to continuously rise over the forecast period. The increase in the drugs abuse creates a huge demand for the drugs of abuse testing products.

03 December 2020

Read

Visiongain Publishes Controlled Substance Market Report 2021-2031

Continuous increasing prevalence of chronic pain is increasing demand for controlled substance as treatment for Chronic pain. Due to which increasing prevalence of chronic pain around the world is working as a driver for the controlled substance market.

03 December 2020

Read

Visiongain Publishes Companion Animal Diagnostics Market Report 2021-2031

All regions are facing rapid growth in the companion animal population. Companion animal are at high risk of developing various diseases for which companion animal require timely diagnosis for the identification, detection and treatment for life causing diseases.

03 December 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever